Dihydropyrimidinase

Dihydropyrimidinase is an enzyme that plays a crucial role in the pyrimidine degradation pathway. It catalyzes the reversible hydrolytic ring opening of dihydropyrimidines to N-carbamoyl-β-alanine and N-carbamoyl-β-aminoisobutyric acid. This enzyme is essential for the proper metabolism of pyrimidine bases such as thymine and uracil.
Function[edit]
Dihydropyrimidinase is involved in the second step of the pyrimidine degradation pathway. The enzyme facilitates the conversion of dihydropyrimidines, which are produced from the reduction of pyrimidine bases, into N-carbamoyl-β-alanine and N-carbamoyl-β-aminoisobutyric acid. These products are further processed into β-alanine and β-aminoisobutyric acid, which can enter various metabolic pathways.
Structure[edit]
Dihydropyrimidinase is a metalloenzyme that requires a divalent metal ion, typically zinc or cobalt, for its catalytic activity. The enzyme is a homotetramer, meaning it consists of four identical subunits. Each subunit contains a metal-binding site that is essential for its enzymatic function.
Genetic Information[edit]
The gene encoding dihydropyrimidinase in humans is known as DPYS. Mutations in the DPYS gene can lead to a rare metabolic disorder known as dihydropyrimidinase deficiency. This condition is characterized by the accumulation of dihydropyrimidines in the urine and can result in neurological and developmental abnormalities.
Clinical Significance[edit]
Dihydropyrimidinase deficiency is an autosomal recessive disorder that can present with a variety of symptoms, including developmental delay, seizures, and intellectual disability. Diagnosis is typically made through the detection of elevated levels of dihydropyrimidines in the urine and confirmed by genetic testing.
Related Enzymes[edit]
Dihydropyrimidinase is part of a family of enzymes involved in pyrimidine metabolism. Other related enzymes include dihydropyrimidine dehydrogenase and β-ureidopropionase, which catalyze different steps in the degradation of pyrimidine bases.
Research and Applications[edit]
Research on dihydropyrimidinase has implications for understanding metabolic disorders and developing potential treatments. The enzyme is also of interest in the field of biotechnology for its potential use in the bioremediation of pyrimidine-based pollutants.
See Also[edit]
References[edit]
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
